J&J says it lacks consent to provide documents to Carefirst in Stelara suit
MLex Summary: Johnson & Johnson, accused in a lawsuit by Carefirst of unlawfully delaying the introduction of biosimilar competition for autoimmune treatment Stelara, filed a response to Carefirst's motion to compel discovery...To view the full article, register now.
Already a subscriber? Click here to view full article